Fundacion Santa Fe de Bogota
About Fundacion Santa Fe de Bogota
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
3
Pfizer
3
Fundación Santa Fe de Bogota
2
Hoffmann-La Roche
2
AO Innovation Translation Center
1
Aragon Pharmaceuticals, Inc.
1
Boehringer Ingelheim
1
Corvus Pharmaceuticals, Inc.
1
FibroGen
1
Fundacion Clinica Valle del Lili
1
Hospital Infantil Universitario de San Jose
1
Clinical Trials at Fundacion Santa Fe de Bogota
During the past decade, Fundacion Santa Fe de Bogota conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
2006-01-18
2015-08-06
Completed
571
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
2008-02-05
2015-05-27
Completed
502
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
2013-08-28
2020-06-05
Completed
281
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
2014-07-22
2017-06-05
Completed
2,725
Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas
2015-11-01
2018-11-01
Suspended
50
Radiologic and Clinical Outcomes of Augmentation in Fragility Intertrochanteric Hip Fracture Treatment
2015-11-01
2017-12-01
Unknown status
90
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fundacion Santa Fe de Bogota" #1 sponsor was "Actelion" with 3 trials, followed by "Pfizer" with 3 trials
sponsored, "Fundación Santa Fe de Bogota" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "AO Innovation Translation Center"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Santa Fe de Bogota"
#1 collaborator was "Clinica de La Mujer" with 1 trials as a collaborator, "Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)" with 1 trials as a collaborator, "Fundación Santa Fe de Bogota" with 1 trials as a collaborator, "Haukeland University Hospital" with 1 trials as a collaborator and "Hospital Fernandez" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Fundacion Santa Fe de Bogota
According to Clinical.Site data, the most researched conditions in "Fundacion Santa Fe de Bogota" are
"Chronic Myeloid Leukemia" (3 trials), "Covid-19" (2 trials), "Hip Fractures" (2 trials), "Multiple Myeloma" (2 trials) and "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Fundacion Santa Fe de Bogota" in a lesser frequency.
Clinical Trials Intervention Types at Fundacion Santa Fe de Bogota
Most popular intervention types in "Fundacion Santa Fe de Bogota" are "Drug" (15 trials), "Other" (7 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Bosutinib" (2 trials), "Standard care" (2 trials), "ADT (Standard of Care)" (1 trials) and "All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics." (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fundacion Santa Fe de Bogota
The vast majority of trials in "Fundacion Santa Fe de Bogota" are
20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Fundacion Santa Fe de Bogota
Currently, there are NaN active trials in "Fundacion Santa Fe de Bogota".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Fundacion Santa Fe de Bogota,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Fundacion Santa Fe de Bogota, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".